Budweiser Partners with Football Icons Erling Haaland and Jürgen Klopp to Unleash New “Let it Pour” Platform for FIFA World Cup 2026™ April 28, 2026 The platform extends across more than forty countries, bringing fans together with a new global film featuring Haaland and Klopp, limited edition apparel, and legendary fan experiences
CoStar Data Shows London Southern Fringe Office Leasing Reached Nine-Year High April 28, 2026 Increased activity among smaller occupiers in 2025 drove leasing volumes in London’s Southern Fringe to their highest level since 2016, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428881126/en/ Leasing rose to [...]
Microsoft and Postel: An Innovative New Data and AI-Driven Solution to Optimize Italian SMEs’ Relationships with Their Customers April 28, 2026 Microsoft and Postel, a Poste Italiane Group company, announce an evolution of their collaboration and of the agreements they have signed for the digitalization of Italian businesses, welcoming Audiencerate as technology partner in the Data and Direct & Digital Marketing space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427013396/en/ The agreement provides [...]
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid April 27, 2026 AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one-time gene silencing in the central nervous system AviadoBio will present key data on AVB-406 at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy April 27, 2026 Coramitug is a potential best-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3 Coramitug is being evaluated by Novo Nordisk in the ongoing Phase 3 CLEOPATTRA clinical trial in ~1280 participants with ATTR-CM; primary completion expected in 2029 The Fast Track Designation underscores the unmet need within ATTR-CM and could expedite the review of coramitug
KBRA Releases UK RMBS Indices: Q1 2026 April 27, 2026 KBRA releases its UK RMBS Indices: Q1 2026. The indices track key credit performance metrics, including early- (30+ days delinquent (DQ)), mid- (60+ days DQ), late-stage (90+ days DQ) delinquencies, annualised net losses, and prepayment activity, across prime, buy-to-let (BTL), and nonconforming (NC) mortgage collateral. Click here to view the report. Recent Publications UK RMBS [...]
KBRA Releases Research – Extension Risk in UK Seasoned Interest-Only Mortgages April 27, 2026 KBRA releases research that examines the UK past-term interest-only (PTIO) mortgage population, including drivers of post-maturity behaviour and implications for residential mortgage-backed securities (RMBS) cash flow timing. PTIO mortgages are interest-only (IO) loans that have reached maturity without repaying the principal balance. These loans are gaining prominence as legacy pre-global financial crisis (GFC) IO cohorts [...]
Microland Launches Strategic Blueprint to Help Enterprises Enable Autonomous, AI-First Operations April 27, 2026 Microland, a leading AI-first, platform-led technology infrastructure services company, today announced the release of a strategic blueprint, “Architecting Autonomous Operations: Powered by AI and a Platform-Led Technology Fabric.” This report provides a blueprint for enterprises seeking to modernize their technology infrastructure for an AI-first world. It positions autonomous, platform-led operations as a strategic imperative -not [...]
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status April 27, 2026 Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion
Hitmarker Launches “Hitmarker Pro,” a New End-to-End Hiring Platform Built specifically for the Gaming Industry April 27, 2026 From number 1 job board in Gaming to full hiring infrastructure, Hitmarker introduces a subscription platform to help gaming companies attract, manage, and hire talent in one place.